Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimization of ICG in Fluorescent Cholangiography (DOTIG)
NCT05419947Phase 4Completed
- Sponsor
- Fundación Instituto de Ciencias de la Salud de Castilla y León
- Start
- Jun 2022
- Primary completion
- May 2023
- Countries
- 1
01
Overview
A Phase 4 trial of indocyanine green in cholelithiasis, cholecystitis, gallbladder polyp, Gallbladder adenomyomatosis (GA), sponsored by Fundación Instituto de Ciencias de la Salud de Castilla y León. Started Jun 2022; status: completed.
02
Drugs
indocyanine green
03
Conditions
cholelithiasischolecystitisgallbladder polypGallbladder adenomyomatosis (GA)
Beyond the preview
Go deeper on NCT05419947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05419947.